GDS Wealth Management’s Boston Scientific BSX Stock Holding History

GDS Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.53M	Buy	135,991 +6,640	+5%	+$531K	0.51%	66
2025 Q4	$12.3M	Buy	129,351 +7,274	+6%	+$713K	0.77%	53
2025 Q3	$11.9M	Buy	122,077 +9,428	+8%	+$976K	0.79%	55
2025 Q2	$12.1M	Buy	112,649 +40,528	+56%	+$4.1M	0.88%	48
2025 Q1	$7.28M	Buy	72,121 +50,525	+234%	+$5.09M	0.62%	51
2024 Q4	$1.93M	Buy	21,596 +15,747	+269%	+$1.39M	0.18%	79
2024 Q3	$490K	Buy	+5,849	New	+$461K	0.05%	100

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GDS Wealth Management's BSX Position: Q1 2026 in Review

GDS Wealth Management increased its Boston Scientific (BSX) stake by 5.1% in Q1 2026, buying an estimated $531K and bringing the position to 135,991 shares worth $8.53M. The position accounts for 0.51% of the portfolio, ranked #66.

GDS Wealth Management first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $12.3M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

GDS Wealth Management held 135,991 shares of Boston Scientific worth $8.53M as of Q1 2026.
GDS Wealth Management bought 6,640 Boston Scientific shares in Q1 2026, an estimated $531K.
Boston Scientific made up 0.51% of GDS Wealth Management's portfolio in Q1 2026, its #66 holding.
GDS Wealth Management first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
GDS Wealth Management's Boston Scientific position peaked at $12.3M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on GDS Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.